ATE454395T1 - Oestrogenderivate als steroid sulphatase inhibitoren - Google Patents
Oestrogenderivate als steroid sulphatase inhibitorenInfo
- Publication number
- ATE454395T1 ATE454395T1 AT04713124T AT04713124T ATE454395T1 AT E454395 T1 ATE454395 T1 AT E454395T1 AT 04713124 T AT04713124 T AT 04713124T AT 04713124 T AT04713124 T AT 04713124T AT E454395 T1 ATE454395 T1 AT E454395T1
- Authority
- AT
- Austria
- Prior art keywords
- group
- steroid sulphatase
- ring system
- estrogen derivatives
- sulphatase inhibitors
- Prior art date
Links
- 102000009134 Steryl-Sulfatase Human genes 0.000 title 1
- 108010087999 Steryl-Sulfatase Proteins 0.000 title 1
- 229940011871 estrogen Drugs 0.000 title 1
- 239000000262 estrogen Substances 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 230000003637 steroidlike Effects 0.000 abstract 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 abstract 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- ABLZXFCXXLZCGV-UHFFFAOYSA-N Phosphorous acid Chemical group OP(O)=O ABLZXFCXXLZCGV-UHFFFAOYSA-N 0.000 abstract 1
- 150000001336 alkenes Chemical class 0.000 abstract 1
- 150000001412 amines Chemical class 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 125000005647 linker group Chemical group 0.000 abstract 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M nitrite group Chemical group N(=O)[O-] IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 abstract 1
- IIACRCGMVDHOTQ-UHFFFAOYSA-N sulfamic acid Chemical group NS(O)(=O)=O IIACRCGMVDHOTQ-UHFFFAOYSA-N 0.000 abstract 1
- 125000000565 sulfonamide group Chemical group 0.000 abstract 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Tropical Medicine & Parasitology (AREA)
- Communicable Diseases (AREA)
- Transplantation (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Oncology (AREA)
- Psychiatry (AREA)
- AIDS & HIV (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB0306717A GB0306717D0 (en) | 2003-03-24 | 2003-03-24 | Compound |
| GB0315885A GB0315885D0 (en) | 2003-07-07 | 2003-07-07 | Compound |
| PCT/GB2004/000705 WO2004085459A1 (en) | 2003-03-24 | 2004-02-20 | Oestrogen derivatives as inhibitors of steroid sulphatase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE454395T1 true ATE454395T1 (de) | 2010-01-15 |
Family
ID=33099976
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04713124T ATE454395T1 (de) | 2003-03-24 | 2004-02-20 | Oestrogenderivate als steroid sulphatase inhibitoren |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US7893284B2 (de) |
| EP (1) | EP1608671B1 (de) |
| JP (1) | JP4719144B2 (de) |
| AT (1) | ATE454395T1 (de) |
| AU (1) | AU2004224053B2 (de) |
| BR (1) | BRPI0408703A (de) |
| CA (1) | CA2520142C (de) |
| DE (1) | DE602004024966D1 (de) |
| DK (1) | DK1608671T3 (de) |
| EA (1) | EA011123B1 (de) |
| ES (1) | ES2339450T3 (de) |
| HK (1) | HK1082258A1 (de) |
| MX (1) | MXPA05010339A (de) |
| PL (1) | PL378577A1 (de) |
| WO (1) | WO2004085459A1 (de) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0113920D0 (en) | 2001-06-07 | 2001-08-01 | Sterix Ltd | Composition |
| US8030298B2 (en) | 2005-05-26 | 2011-10-04 | Abbott Products Gmbh | 17β-HSD1 and STS inhibitors |
| US8288367B2 (en) | 2006-11-30 | 2012-10-16 | Solvay Pharmaceuticals Gmbh | Substituted estratriene derivatives as 17BETA HSD inhibitors |
| WO2008090517A2 (en) * | 2007-01-26 | 2008-07-31 | Piramal Life Sciences Limited | Enriched plant extract, compound, and methods for the treatment of proliferative disorders |
| EP2149371A1 (de) | 2008-07-28 | 2010-02-03 | PregLem S.A. | Verwendung von Steroid-Sulfatase-Hemmern zur Behandlung von Frühgeburtsleiden |
| US20110190323A1 (en) * | 2008-08-28 | 2011-08-04 | President And Fellows Of Harvard College | Cortistatin analogues and syntheses thereof |
| US20120190659A1 (en) * | 2009-04-22 | 2012-07-26 | Children's Medical Center Corporation | Angiogenesis inhibitors |
| US9388210B2 (en) | 2011-02-25 | 2016-07-12 | Washington University | Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and methods of treatment using same |
| CN108976272B (zh) | 2011-10-14 | 2021-05-25 | 萨奇治疗股份有限公司 | 3,3-二取代的19-去甲孕甾烷化合物、组合物、及其用途 |
| ES2680582T3 (es) | 2012-12-18 | 2018-09-10 | Washington University | Esteroides 19-alcoxi-17-sustituidos neuroactivos, profármacos de los mismos y métodos de tratamiento con los mismos |
| US9512170B2 (en) | 2013-03-01 | 2016-12-06 | Washington University | Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors |
| US9365502B2 (en) | 2013-03-11 | 2016-06-14 | Washington University | Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A receptors |
| US9562026B2 (en) | 2013-03-14 | 2017-02-07 | Washington University | Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A receptors |
| WO2014169836A1 (en) | 2013-04-17 | 2014-10-23 | Sage Therapeutics, Inc. | 19-nor neuroactive steroids and methods of use thereof |
| KR20230172622A (ko) | 2013-04-17 | 2023-12-22 | 세이지 테라퓨틱스, 인크. | 19-노르 c3,3-이치환된 c21-n-피라졸릴 스테로이드 및 그의 사용 방법 |
| US9725481B2 (en) | 2013-04-17 | 2017-08-08 | Sage Therapeutics, Inc. | 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof |
| HUE051403T2 (hu) | 2013-04-17 | 2021-03-01 | Sage Therapeutics Inc | Neuroaktív 19-nor-szteroidok kezelési eljárásokhoz |
| PT3021852T (pt) | 2013-07-19 | 2021-04-21 | Sage Therapeutics Inc | Esteroides neuroativos, composições e utilizações das mesmas |
| CA2921512A1 (en) | 2013-08-23 | 2015-02-26 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| EA201891279A1 (ru) | 2013-12-24 | 2019-01-31 | Президент Энд Феллоус Оф Гарвард Колледж | Аналоги кортистатина, их синтез и применения |
| WO2015195962A1 (en) | 2014-06-18 | 2015-12-23 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| HUE051488T2 (hu) | 2014-10-16 | 2021-03-01 | Sage Therapeutics Inc | Készítmények és eljárások központi idegrendszeri rendellenességek kezelésére |
| US10577390B2 (en) | 2014-10-16 | 2020-03-03 | Sage Therapeutics, Inc. | Compositions and methods for treating CNS disorders |
| EP3719029A1 (de) | 2014-11-27 | 2020-10-07 | Sage Therapeutics, Inc. | Zusammensetzungen zur induzierung von sedation |
| DK3250210T3 (da) | 2015-01-26 | 2021-03-08 | Sage Therapeutics Inc | Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser |
| US10329320B2 (en) | 2015-02-20 | 2019-06-25 | Sage Therapeutics, Inc. | Neuroactive steroids, compositions, and uses thereof |
| EP3294298A4 (de) | 2015-05-08 | 2018-10-17 | President and Fellows of Harvard College | Cortistatin-analoga, synthese und verwendungen |
| EP3316889A4 (de) | 2015-07-01 | 2018-11-14 | President and Fellows of Harvard College | Cortistatin-analoga sowie synthese und verwendungen davon |
| WO2017217180A1 (ja) * | 2016-06-15 | 2017-12-21 | ソニー株式会社 | 情報処理装置、観察システム、観察方法及びプログラム |
| RU2019103590A (ru) | 2016-07-11 | 2021-02-11 | Сейдж Терапьютикс, Инк. | С17-, с20- и с21-замещенные нейроактивные стероиды и способы их применения |
| JP2022534424A (ja) | 2019-05-31 | 2022-07-29 | セージ セラピューティクス， インコーポレイテッド | 神経刺激性ステロイド及びその組成物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4994439A (en) * | 1989-01-19 | 1991-02-19 | California Biotechnology Inc. | Transmembrane formulations for drug administration |
| DE19723794A1 (de) * | 1997-06-06 | 1998-12-10 | Jenapharm Gmbh | Nichtestrogene Derivate des Estradiols mit antioxidativer Aktivität |
| US6288050B1 (en) * | 1997-07-18 | 2001-09-11 | Duquesne University Of The Holy Ghost | Steroid sulfatase inhibitors and methods for making and using the same |
| GB2331987B (en) * | 1997-12-04 | 2002-11-27 | Imperial College | Polycyclic sulphamate inhibitors of oestrone sulphatase |
| US6046186A (en) * | 1997-12-24 | 2000-04-04 | Sri International | Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| CA2334119C (en) * | 1998-06-10 | 2011-09-13 | Sterix Limited | Pharmaceutical composition with tumor necrosis factor a and 2-methoxyestrone-3-o-sulphamate for inhibition of estrone sulphatase |
| EP1173182A2 (de) * | 1999-04-30 | 2002-01-23 | Sterix Limited | Verwendung von estron-derivaten als antikrebs-mittel |
| JPWO2001081364A1 (ja) * | 2000-04-24 | 2004-01-08 | 協和醗酵工業株式会社 | エストラ−１，３，５（１０）−トリエン誘導体 |
| NZ523042A (en) * | 2000-05-11 | 2004-05-28 | Res Inst Medicine Chem | 2-substituted pregna-1, 3, 5 (10) -triene and chola-1, 3, 5 (10)-triene derivatives and their biological activity |
| CA2418479C (en) * | 2000-08-18 | 2007-12-18 | The Board Of Trustees Of The University Of Illinois | Prodrugs of betulinic acid derivatives for the treatment of cancer |
| GB0020498D0 (en) * | 2000-08-18 | 2000-10-11 | Sterix Ltd | Compound |
| WO2002062347A1 (en) | 2001-02-05 | 2002-08-15 | Oncology Sciences Corporation | Method and composition of novel compounds for the therapy and targeting of the primary modalities of cancer cell proliferation and homeostasis |
| GB0421106D0 (en) * | 2004-09-22 | 2004-10-27 | Sterix Ltd | Compound |
-
2004
- 2004-02-20 BR BRPI0408703-8A patent/BRPI0408703A/pt not_active IP Right Cessation
- 2004-02-20 PL PL378577A patent/PL378577A1/pl not_active Application Discontinuation
- 2004-02-20 EA EA200501426A patent/EA011123B1/ru not_active IP Right Cessation
- 2004-02-20 ES ES04713124T patent/ES2339450T3/es not_active Expired - Lifetime
- 2004-02-20 AT AT04713124T patent/ATE454395T1/de not_active IP Right Cessation
- 2004-02-20 CA CA2520142A patent/CA2520142C/en not_active Expired - Fee Related
- 2004-02-20 WO PCT/GB2004/000705 patent/WO2004085459A1/en active Application Filing
- 2004-02-20 DE DE602004024966T patent/DE602004024966D1/de not_active Expired - Lifetime
- 2004-02-20 EP EP04713124A patent/EP1608671B1/de not_active Expired - Lifetime
- 2004-02-20 MX MXPA05010339A patent/MXPA05010339A/es active IP Right Grant
- 2004-02-20 AU AU2004224053A patent/AU2004224053B2/en not_active Ceased
- 2004-02-20 DK DK04713124.8T patent/DK1608671T3/da active
- 2004-02-20 JP JP2006505892A patent/JP4719144B2/ja not_active Expired - Fee Related
-
2005
- 2005-09-23 US US11/233,945 patent/US7893284B2/en not_active Expired - Fee Related
-
2006
- 2006-03-29 HK HK06103924.9A patent/HK1082258A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1608671A1 (de) | 2005-12-28 |
| US20060094696A1 (en) | 2006-05-04 |
| BRPI0408703A (pt) | 2006-03-07 |
| HK1082258A1 (en) | 2006-06-02 |
| US7893284B2 (en) | 2011-02-22 |
| MXPA05010339A (es) | 2005-12-14 |
| DK1608671T3 (da) | 2010-05-10 |
| AU2004224053A1 (en) | 2004-10-07 |
| DE602004024966D1 (de) | 2010-02-25 |
| CA2520142C (en) | 2011-01-04 |
| AU2004224053B2 (en) | 2011-06-09 |
| EA200501426A1 (ru) | 2006-06-30 |
| CA2520142A1 (en) | 2004-10-07 |
| PL378577A1 (pl) | 2006-05-02 |
| EA011123B1 (ru) | 2008-12-30 |
| ES2339450T3 (es) | 2010-05-20 |
| JP2006521335A (ja) | 2006-09-21 |
| WO2004085459A1 (en) | 2004-10-07 |
| JP4719144B2 (ja) | 2011-07-06 |
| EP1608671B1 (de) | 2010-01-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE454395T1 (de) | Oestrogenderivate als steroid sulphatase inhibitoren | |
| DOP2011000301A (es) | Derivados de azaadamantano y metodos de uso de los mismos | |
| CO6150144A2 (es) | Inhibidores de proteina tirosina fosfatasa humana y metodos de uso | |
| HUP0002976A2 (hu) | Keményfelület tisztító készítmény | |
| ES2185338T3 (es) | Derivados de fumagilol y procedimientos para su fabricacion. | |
| DE60205891D1 (de) | Steroide als agonisten für fxr | |
| TR200101906T2 (tr) | Antiviral ajanlar olarak kuinolinkarboksamitler | |
| ATE283253T1 (de) | Substituierte aminopropoxyarylderivate als lxr agonisten | |
| CR9375A (es) | Derivados de ciclopropanocarboxamida | |
| AR006390A1 (es) | Derivados de lactama | |
| CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
| AR067613A1 (es) | Inhibidores de adn-pk, uso y sintesis de los mismos | |
| DE60032440D1 (de) | Halterung für die Brennkammer einer Gasturbine | |
| DK1311619T3 (da) | Anvendelse af en bitumen/vokssammensætning | |
| ES2175989T3 (es) | Derivado de testosterona. | |
| ATE411287T1 (de) | Neue metallproteinaseinhibitoren | |
| WO2006032885A3 (en) | 2-substituted estrogen sulphamates for inhibition of steroid sulphatase | |
| AR064306A1 (es) | Antagonistas del receptor de angiotensina ii | |
| DK1051177T3 (da) | Steroide 3-O-Sulfamatderivater som inhibitorer af östronsulfatase | |
| ATE218060T1 (de) | Zusammenstellungen die beta-amyloid protein bedingte zytotoxizität verhindern | |
| AR028743A1 (es) | DERIVADOS DE N-TRIAZOLILMETIL-PIPERAZINA CON ACCIoN ANTAGONISTA DE RECEPTORES DE NEUROQUININA | |
| ATE256696T1 (de) | Neue cofaktoren für methyltransferasen | |
| RS54039B1 (en) | RADIO-LABELED PHENYLIMIDAZOLE LIGANDS | |
| TW200502695A (en) | Basic compound, resist composition and patterning process | |
| MX2008011292A (es) | Compuestos esteroidales como inhibidores de esteroide sulfatasa. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |